The Living Guidelines: STEMI
You don't need to be Editor-In-Chief to add or edit content to WikiDoc. You can begin to add to or edit text on this WikiDoc page by clicking on the edit button at the top of this page. Next enter or edit the information that you would like to appear here. Once you are done editing, scroll down and click the Save page button at the bottom of the page.
| Cardiology Network |
| Discuss The Living Guidelines: STEMI further in the WikiDoc Cardiology Network |
| Adult Congenital |
|---|
| Biomarkers |
| Cardiac Rehabilitation |
| Congestive Heart Failure |
| CT Angiography |
| Echocardiography |
| Electrophysiology |
| Cardiology General |
| Genetics |
| Health Economics |
| Hypertension |
| Interventional Cardiology |
| MRI |
| Nuclear Cardiology |
| Peripheral Arterial Disease |
| Prevention |
| Public Policy |
| Pulmonary Embolism |
| Stable Angina |
| Valvular Heart Disease |
| Vascular Medicine |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Phone:617-632-7753
Associate Editor: Cafer Zorkun, M.D., Ph.D. [2]
Please Join in Editing This Page and Apply to be an Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [3] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.
Any recommendations found on these pages are for education use only. Wikidoc is not a substitute for a licensed healthcare provider. Please see the disclaimers page for important information regarding limitations of the information found here. In suggesting edits to the guidelines, Wikidoc suggests that the following classification scheme be used. Read more about the classification scheme used by the ACC / AHA Guidelines Committee here.
Pharmacotherapy
Recommendations for Antiplatelet Agents / Anticoagulants Therapy: Aspirin [1]
CLASS I
Click here to comment on this section of the current guidelines
Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same
Suggest Revisions to the Guidelines
CLASS IIa
Click here to comment on this section of the current guidelines
Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same
Suggest Revisions to the Guidelines
Recommendations for Antiplatelet Agents / Anticoagulants Therapy: Clopidogrel [1]
CLASS I
Click here to comment on this section of the current guidelines
Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same
Suggest Revisions to the Guidelines
CLASS IIa
Click here to comment on this section of the current guidelines
Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same
Suggest Revisions to the Guidelines
Recommendations for Antiplatelet Agents / Anticoagulants Therapy: Warfarin [1]
CLASS I
Click here to comment on this section of the current guidelines
Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same
Suggest Revisions to the Guidelines
Recommendations for Beta Blocker Therapy [1]
CLASS I
Click here to comment on this section of the current guidelines
Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same
Suggest Revisions to the Guidelines
CLASS IIa
Click here to comment on this section of the current guidelines
Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same
Suggest Revisions to the Guidelines
CLASS III
Click here to comment on this section of the current guidelines
Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same
Suggest Revisions to the Guidelines
Recommendations for ACE Inhibitors Therapy
CLASS I
Click here to comment on this section of the current guidelines
Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same
Suggest Revisions to the Guidelines
CLASS IIa
Click here to comment on this section of the current guidelines
Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same
Suggest Revisions to the Guidelines
Recommendations for Angiotensin Receptor Blockers Therapy
CLASS I [1]
Click here to comment on this section of the current guidelines
Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same
Suggest Revisions to the Guidelines
CLASS IIb [1]
Click here to comment on this section of the current guidelines
Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same
Suggest Revisions to the Guidelines
Recommendations for Aldosterone Blockers Therapy
CLASS I [1]
Click here to comment on this section of the current guidelines
Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same
Suggest Revisions to the Guidelines
Recommendations for Inhibition of the Renin-Angiotensin-Aldosterone System
CLASS I [1]
Click here to comment on this section of the current guidelines
Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same
Suggest Revisions to the Guidelines
CLASS IIa [1]
Click here to comment on this section of the current guidelines
Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same
Suggest Revisions to the Guidelines
CLASS IIb [1]
Click here to comment on this section of the current guidelines
Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same
Suggest Revisions to the Guidelines
Recommendations for Influenza Vaccination [1]
CLASS I
Click here to comment on this section of the current guidelines
Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same
Suggest Revisions to the Guidelines
Reperfusion
Primary Invasive or Pharmacological Approach [1]
CLASS I
Click here to comment on this section of the current guidelines
Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same
Suggest Revisions to the Guidelines
Facilitated PCI [1]
CLASS IIb
Click here to comment on this section of the current guidelines
Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same
Suggest Revisions to the Guidelines
CLASS III
Click here to comment on this section of the current guidelines
Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same
Suggest Revisions to the Guidelines
Immediate (or Emergency) Invasive Strategy and Rescue PCI [1]
Class I
Click here to comment on this section of the current guidelines
Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same
Suggest Revisions to the Guidelines
Class IIa
Click here to comment on this section of the current guidelines
Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same
Suggest Revisions to the Guidelines
Class IIb
Click here to comment on this section of the current guidelines
Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same
Suggest Revisions to the Guidelines
Class III
Click here to comment on this section of the current guidelines
Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same
Suggest Revisions to the Guidelines
PCI after Successful Fibrinolysis or for Patients not Undergoing Primary Reperfusion [1]
Class IIb
Click here to comment on this section of the current guidelines
Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same
Suggest Revisions to the Guidelines
Class III
Click here to comment on this section of the current guidelines
Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same
Suggest Revisions to the Guidelines
Anticoagulants as Ancillary Therapy [1]
Class I
Click here to comment on this section of the current guidelines
Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same
Suggest Revisions to the Guidelines
Anticoagulants for STEMI patients who do not undergo reperfusion therapy [1]
Class IIa
Click here to comment on this section of the current guidelines
Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same
Suggest Revisions to the Guidelines
Class III
Click here to comment on this section of the current guidelines
Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same
Suggest Revisions to the Guidelines
Thienopyridines [1]
Class I
Click here to comment on this section of the current guidelines
Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same
Suggest Revisions to the Guidelines
Class IIa
Click here to comment on this section of the current guidelines
Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same
Suggest Revisions to the Guidelines
Reference
- ↑ 1.00 1.01 1.02 1.03 1.04 1.05 1.06 1.07 1.08 1.09 1.10 1.11 1.12 1.13 1.14 1.15 1.16 1.17 Antman EM, Hand M, Armstrong PW, et al (January 2008). "2007 Focused Update of the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines: developed in collaboration With the Canadian Cardiovascular Society endorsed by the American Academy of Family Physicians: 2007 Writing Group to Review New Evidence and Update the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction, Writing on Behalf of the 2004 Writing Committee". Circulation 117 (2): 296–329. doi:10.1161/CIRCULATIONAHA.107.188209. PMID 18071078.
Acknowledgement and Attribution Regarding Sources of Content
Some of the initial content on this page may be incorporated in part from copyleft sources in the public domain including wikis such as Wikipedia and AskDrWiki. Drug information for patients came from the The National Library of Medicine. Infectious disease information may have come from the Centers for Disease Control (CDC). Differential Diagnoses are drawn from clinicians as well as an amalgamation of 3 sources: 1.The Disease Database; 2. Kahan, Scott, Smith, Ellen G. In A Page: Signs and Symptoms. Malden, Massachusetts: Blackwell Publishing, 2004:3; 3. Sailer, Christian, Wasner, Susanne. Differential Diagnosis Pocket. Hermosa Beach, CA: Borm Bruckmeir Publishing LLC, 2002:7 .

